{"filing":{"accession_number":"0001493152-26-048022","cik":"0001904286","ticker":"MIRA","company_name":"MIRA PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-22","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226048022/form8-k.htm"},"events":[{"id":37059,"run_id":34159,"accession_number":"0001493152-26-048022","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"MIRA Pharmaceuticals disclosed positive preclinical study results for MIRA-55 in a chronic inflammatory pain model, demonstrating efficacy comparable to celecoxib without tolerance. The filing is disclosed under Item 7.01 (Regulation FD Disclosure) and represents a material operational/clinical development milestone supporting advancement toward an IND submission in Q1 2027. While not a traditional earnings release or financial event, the positive preclinical data is material to investors' assessment of the company's drug development pipeline and clinical prospects.","company_name":"MIRA PHARMACEUTICALS, INC.","ticker":"MIRA","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":41645,"accession_number":"0001493152-26-048022","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"MIRA Pharmaceuticals disclosed positive preclinical study results for MIRA-55 in a chronic inflammatory pain model, demonstrating efficacy comparable to celecoxib without tolerance. The filing is disclosed under Item 7.01 (Regulation FD Disclosure) and represents a material operational/clinical development milestone supporting advancement toward an IND submission in Q1 2027. While not a traditional earnings release or financial event, the positive preclinical data is material to investors' assessment of the company's drug development pipeline and clinical prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T12:01:46.170896+00:00","company_name":"MIRA PHARMACEUTICALS, INC.","ticker":"MIRA","filing_date":"2026-10-22"}]}